Mannkind MNKD Onbody Infusor — Finite Lived Intangible Assets Gross

Similar metrics at other companies

VLYFinite Lived Intangible Assets - Gross

$385.68M-1.8%

IFFFinite Lived Intangible Assets - Gross

$9.46B+0.9%

NVTFinite Lived Intangible Assets - Gross

$2.15B+25.5%

HSICFinite Lived Intangible Assets - Gross

$1.66B+6.5%

EVRFinite Lived Intangible Assets - Gross

$33.82M—

SOFinite Lived Intangible Assets - Gross

$669M—

Questions, answered.

What is Mannkind's onbody infusor — finite lived intangible assets gross?

Mannkind (MNKD) reported onbody infusor — finite lived intangible assets gross of $194M in Q1 2026.

What does onbody infusor — finite lived intangible assets gross mean?

This represents the total historical cost of finite-lived intangible assets specifically attributed to the Onbody Infusor product line. It reflects the initial investment in intellectual property, patents, or acquired technology before accounting for any accumulated amortization. Monitoring this value helps investors understand the scale of capital deployed into the development or acquisition of this specific segment's intangible portfolio.